APOE-ε4 in patients with Alzheimer disease and vascular dementia

Alzheimer Disease and Associated Disorders

Volumn 10, Issue 4, 1996, Pages 189-191

  Treves, T A ^a,b   Bornstein, N M ^a   Chapman, J ^a   Klimovitzki, S ^a   Verchovsky, R ^a   Asherov, A ^a   Veshchev, I O ^a   Korczyn, A D ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Alzheimer disease; APOE 4; Apolipoprotein E; Epidemiology; Primary degenerative dementia; Vascular dementia

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN DEGENERATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; PRIORITY JOURNAL; STROKE; ALLELE; GENETICS; GENOTYPE; METABOLISM;

AGED; ALLELES; ALZHEIMER DISEASE; APOLIPOPROTEINS E; DEMENTIA, VASCULAR; FEMALE; GENOTYPE; HUMANS; MALE;

EID: 0029658476     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002093-199601040-00003     Document Type: Article

References (31)

1. Amouyel P, Brousseau T, Fruchart J-C, et al. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet 1993;342:1309.
2. Amouyel P, Vidal O, Launay J-M, et al. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. Lancet 1994;344:1315-8.
3. Chapman J, Estupinan J, Asherov A, et al. A simple and efficient method for Apolipoprotein E genotype determination. Neurology 1996;46:1484-5.
4. Cumming AL, Robertson FW. Polymorphism at the apoprotein-E locus in relation to risk of coronary disease. Clin Genet 1984;25:310-3.
5. DSM-III-R (Diagnostic and Statistical Manual of Mental Disorders. 3rd ed.-rev.). Washington, DC: American Psychiatric Association, 1987.
6. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
7. Friedman G, Gabizon R, Shapira A, et al. Association of Eε4 alleles with Alzheimer's disease but not with Down's syndrome or Creutzfeldt-Jakob disease. Alzheimers Res 1995;1:45-8.
8. Frisoni GB, Calabresi L, Geroldi C, et al. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia 1994;5:240-2.
9. Gearing M, Schneider JA, Rebeck GW, et al. Alzheimer's disease with and without coexisting Parkinson's disease changes: apolipoprotein E genotype and neuropathologic correlates. Neurology 1995;45:1985-90.
10. Goldfarb LG, Chapman J, Brown P, et al. Apoliporotein E genotype in human spongiform encephalopathies. Neurology 1996;46:A187.
11. Hachinski VC, Hiff LD, Zilhka E, et al. Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
12. Hendrie HC, Hall KS, Hui S, et al. Apolipoprotein E genotypes and Alzheimer's disease in a community study of elderly African Americans. Ann Neurol 1995;37:118-20.
13. Korczyn AD. The clinical differential diagnosis of dementia: concept and methodology. Psychiatr Clin North Am 1991;14:237-49.
14. Kotila M, Waltimo O, Niemi M-L, et al. Dementia after stroke. Eur Neurol 1986;25:134-40.
15. Lucotte G, David F, Visvikis S, et al. Apolipoprotein E-ε4 allele and Alzheimer's disease. Lancet 1993;342:1309.
16. Maestre G, Ottman R, Stern Y, et al. Apolipoprotein E and Alzheimer's disease: ethnic variation in genotypic risks. Ann Neurol 1995;37:254-59.
17. Mak YT, Chiu H, Woo J, et al. Apolipoprotein E genotype and Alzheimer's disease in Hong Kong elderly Chinese. Neurology 1996;46:146-9.
18. Mayeux R, Stern Y, Ottman R, et al. The apolipoprotein ε4 allele in patients with Alzheimer's disease. Ann Neurol 1993;34:752-4.
19. McKahnn G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984;34:939-44.
20. Muramatsu T, Higuchi S, Arai H, et al. Apolipoprotein E ε4 allele distribution in alcoholic dementia and in Alzheimer's disease in Japan. Ann Neurol 1994;36:797-9.
21. Nalbantoglu J, Gilfix BM, Bertrand P, et al. Predictive value of apolipoprotein E genotyping in Alzheimer's disease: results of an autopsy series and an analysis of several combined studies. Ann Neurol 1994;36: 889-95.
22. Noguchi S, Murakami K, Yamada N. Apoliporotein E genotype and Alzheimer's disease. Lancet 1993;342:737.
23. Nussbaum M, Treves TA, Korczyn AD. DSM-III-R criteria for primary degenerative dementia and multi-infarct dementia. Alzheimer Dis Assoc Disord 1992;6:111-7.
24. Sakoda S, Sasaki J, Kuriyama M, et al. Apolipoprotein E ε4. Neurology 1994;44:2420-1.
25. Saunders AM, Schmader K, Breitner JCS, et al. Apolipoprotein E ε4 allele distributions in late-onset Alzheimer's disease and in other amyloid-forming diseases. Lancet 1993;342:710-1.
26. Schneider JA, Gearing M, Mirra SS. Apolipoprotein E (ApoE) genotype in diverse neurodegenerative diseases (ND). Brain Pathol 1994;4:538.
27. Tabaton M, Rolleri M, Masturzo P, et al. Apoliporotein E ε4 allele frequency is not increased in progressive supranuclear palsy. Neurology 1995;45:1764-5.
28. Victoroff J, Mack WJ, Lyness SA, Chui HC. Multicenter clinicopathological correlation in dementia. Am J Psychiatry 1995;152:1476-84.
29. Waring SC, O'Brien PC, Kurland LT, et al. Apolipoprotein E allele in Chamorros with amyotrophic lateral sclerosis/parkinsonism-dementia complex. Lancet 1994;343:611.
30. Wenham PR, Price WH, Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet 1991;337:1158-9.
31. Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, et al. Dose-dependent association of apolipoprotein E allele ε4 with late-onset, sporadic Alzheimer's disease. Ann Neurol 1994;36:656-9.